The Center of Innovation for Nanobiotechnology (COIN) announced the upcoming Nano&Bio Executive Roundtable event to be hosted at The RTP Foundation on November 17, 2011, beginning at 5 pm.
This Roundtable will exp...
The Phase 2 program findings of non-steroidal anti-inflammatory drugs (NSAIDs) formulated by Iroko Pharmaceuticals utilizing its partner’s iCeutica’s proprietary SoluMatrix nanotechnology platform, will be presented at the American College of Rheumatology’s annual meeting on 7 November 2011 in Chicago.
University of Copenhagen researchers have achieved a major milestone in that they have been able to handle reactions at extremely small volumes, i.e., 10-19 L. This is nearly billion times smaller than anyone has ever handled previously.
Case Western Reserve University researchers have discovered that a hard nanocomposite probe, when implanted in a rat model’s cerebral cortex becomes as flexible as the surrounding gray matter in a few minutes ensuring that scarring does not occur as in traditional probes.
EuroNanoMed, an European funding program under the European Commission’s ERA-Net scheme for the advancement of transnational nanomedicine research, has declared that eight projects were selected through its third and final joint transnational call for partnership research projects will get the €8 million fund offered by the funding agencies of EuroNanoMed.
Children's Hospital Los Angeles, as part of its current research program on nanoparticle-based therapy for Ewing's sarcoma has signed a research partnership with NanoSmart Pharmaceuticals, a developer of innovative cancer drugs, to develop and validate the novel drug-delivery platform of the company.
Reliable and accurate single-molecule medical diagnosis is a step closer to reality with the development a new technique by Cambridge University researchers which uses sub-nanometre "cages" to capture and ident...
The healthcare market is poised to see some of the earliest benefits of nanotechnology. Over the next decade, it will be one of nanotech's highest growth sectors.
Targeted drug delivery therapies for the treatmen...
Researchers from the Institute of Physical Chemistry of the Polish Academy of Sciences have conducted studies which suggest that carbon nanoparticles can be used to measure the amount of dopamine present in solutions even if there is interference due to the presence of ascorbic and uric acids.
A team of scientists from LLC, Senior Scientific, School of Medicine and Cancer Research and Treatment Center-University of Mexico, Sandia National Laboratories-based Integrated Nanotechnologies Facility designed nanoprobes to enable differentiation between cells having HER-2 and the cells not having HER-2.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.